Literature DB >> 29501512

[Clinical overview of auto-inflammatory diseases].

S Georgin-Lavialle1, F Rodrigues2, V Hentgen3, A Fayand2, P Quartier4, B Bader-Meunier4, C Bachmeyer5, L Savey5, C Louvrier6, G Sarrabay7, I Melki8, A Belot9, I Koné-Paut10, G Grateau11.   

Abstract

Monogenic auto-inflammatory diseases are characterized by genetic abnormalities coding for proteins involved in innate immunity. They were initially described in mirror with auto-immune diseases because of the absence of circulating autoantibodies. Their main feature is the presence of peripheral blood inflammation in crisis without infection. The best-known auto-inflammatory diseases are mediated by interleukines that consisted in the 4 following diseases familial Mediterranean fever, cryopyrinopathies, TNFRSF1A-related intermittent fever, and mevalonate kinase deficiency. Since 10 years, many other diseases have been discovered, especially thanks to the progress in genetics. In this review, we propose the actual panorama of the main known auto-inflammatory diseases. Some of them are recurrent fevers with crisis and remission; some others evaluate more chronically; some are associated with immunodeficiency. From a physiopathological point of view, we can separate diseases mediated by interleukine-1 and diseases mediated by interferon. Then some polygenic inflammatory diseases will be shortly described: Still disease, Schnitzler syndrome, aseptic abscesses syndrome. The diagnosis of auto-inflammatory disease is largely based on anamnesis, the presence of peripheral inflammation during attacks and genetic analysis, which are more and more performant.
Copyright © 2018 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Auto-inflammatory diseases; Fièvres récurrentes monogéniques; Interferon-mediated disease; Interleukin-1 mediated-disease; Maladies auto-inflammatoires; Maladies médiées par les interférons; Maladies médiées par l’interleukine-1; Monogenic recurrent fevers

Mesh:

Year:  2018        PMID: 29501512     DOI: 10.1016/j.revmed.2018.01.004

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  2 in total

Review 1.  Notch Signaling Regulation in Autoinflammatory Diseases.

Authors:  Rossella Gratton; Paola Maura Tricarico; Adamo Pio d'Adamo; Anna Monica Bianco; Ronald Moura; Almerinda Agrelli; Lucas Brandão; Luisa Zupin; Sergio Crovella
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

Review 2.  Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood.

Authors:  Tatjana Welzel; Susanne M Benseler; Jasmin B Kuemmerle-Deschner
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.